The UK's Health Secretary, Alan Johnson, has published a new plan to increase preparedness and better protect the public against a possible influenza pandemic. A new clinical countermeasures strategy has been developed to offer increased protection against the effects of a pandemic if a "worst case scenario" happened, the Department of Health said.
Already, the UK government has signed agreements with two drugmakers to supply enough pandemic specific vaccine for the entire population once the strain has been identified, Mr Johnson explained.
The new countermeasures include plans to:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze